Myomo Reports Q3 Revenue Up 22%, Adjusted EBITDA Breakeven
Myomo reported Q3 2026 revenue of $12.3 million, up 22% year over year, and adjusted EBITDA breakeven versus a $2.7 million loss a year earlier. It updated full-year revenue guidance to the upper half of the range raised last quarter.
Myomo reported Q3 2026 revenue of $12.3M, up 22% year over year, and breakeven Adjusted EBITDA versus a $2.7M loss a year earlier. It updated full-year revenue guidance to the upper half of the range raised last quarter.Material DetailsContext by AI AnalystThis is a quarterly results update showing…